Infection Control Market, By Type (Disinfectors, Sterilization, Equipment, Consumable & Accessories, and Services), By End-Users (Hospitals, Clinical Laboratories, Pharmaceutical Companies, and Medical Device Companies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Infection Control Market was valued at US$ 41.2 Billion in 2024 and is projected to grow at a CAGR of 3.00% to reach US$ 54 Billion by 2034.

Infection control is discipline concerned with preventing healthcare-associated infection, a practical sub discipline of epidemiology.  Infection prevention and control plays crucial role in hospital and clinics, as it prevents the spread of infections in healthcare settings. According to World Health Organization, 1 out of 10 patients get an infection while receiving care. Furthermore, 30% of health care-associated infections can be reduced by preventing infection control. Hospital acquired infection is most common in intensive care unit and are significantly associated with increased morbidity and mortality thus infection control affects patient recovery. Surgical site infection, central line associated bloodstream infection, clostridium difficile, methicillin resistant Staphylococcus aureus, ventilator associated Pneumonia, and catheter associated urinary tract infections are most common types of hospital acquired infections. Central venous catheters has become the primary source of hospital acquired bloodstream infections. Surgical site wound infections, urinary tract infections, respiratory, bacteremia, pneumonia, skin infections, and gastrointestinal are most common nosocomial infections. Nosocomial infections develop due to long stay in hospital and produced by viruses, and micro-organisms, by various transmission routes like air, droplet, food, water, contact, and disease carrying vector transmitting infectious pathogen or blood. Bacteria, parasites, fungi, and viruses are main causes of infection. Fever, stiff neck, chilling, sweating, nasal congestion, change in cough, pain with urination, sore throat, are symptoms of infection. Rise in prevalence of hospital acquired infection has given positive impact on Infection control market growth.

Rise in incidence of hospital acquired infection is expected to drive the growth of infection control market. Also rising awareness about several infections and increased hospital admission, owing to the rapidly growing population are other factors anticipated to further aid in growth of the l infection control market over the forecast period. Urbanization has given rise in prevalence of diseases due to unhealthy lifestyle, slum areas, poor nutrition food, lack of exercise etc. Infection in hospital is associated with devices used in surgeries, and others used in medical procedures like ventilators and catheters. Urbanization has led to increase the risk and spread of infectious and communicable diseases. Urbanization has also given rise in surgical procedures due to rising chronic disease like heart disease, diabetes, kidney disease caused due to lack of exercise, unhealthy lifestyle and poor nutrition food. Rise in surgical procedures has increased risk of infection which has become the driving factor in target market growth. Medical equipment like drain tubes, urinary catheters, respiratory equipment, and intravenous drips and infusions has increased risk of hospital-acquired infections. Young children, elder person, and compromised immune system persons are at greater risk for hospital-acquired infection. Use of indwelling catheters, long hospital stays, overuse of antibiotics has become the risk factor in hospital-acquired infection. Moreover, increasing demand for non-disposable surgical equipment in hospitals and increasing number of surgical procedure are other factors expected to fuel growth of the infection control market over the forecast period. According to data published by United Nations in 2018, about 55% of the world’s population resided in urban areas, and it is projected that this percentage will increase over the forecast period. However, the growth in incidence of hospital acquired infections and population in urban areas boosts the demand for Infection Control market.

Restrains of the Infection Control Market:

However, imposition of stringent regulations for the approval of equipment used in sterilization inhibits the growth of the infection control market.

Infection Control Market is segmented based on type, end-users and region.

Type Insight

On the basis of Type Infection Control Market is segmented into Disinfectors, Sterilization, Equipment, Consumable & Accessories, and Services. Equipment has dominated the target market due to rise in surgical and medical procedures. Mostly infection is caused by medical equipment.

End-Users Insights

On the basis of End-Users Infection Control Market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical Companies, and Medical Device Companies. Hospitals has dominated the target market due to rise in hospital acquired infections which has given rise in infection control market.

Regional Insights:

On region the Infection Control Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, availability of skilled medical professionals, well-developed healthcare infrastructure, rising regulatory concerns and government initiatives is anticipated to increase demand for Infection Control in the region.

Report Scope:

Attribute	Details
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Type - Disinfectors, Sterilization, Equipment, Consumable & Accessories, and Services By End-Users - Hospitals, Clinical Laboratories, Pharmaceutical Companies, and Medical Device Companies
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Infection Control Market report based on type, end-users and region:

Infection Control Market, By Type:

• Disinfectors
• Sterilization
• Equipment
• Consumable & Accessories
• Services

Infection Control Market, By End-Users:

• Hospitals
• Clinical Laboratories
• Pharmaceutical Companies
• Medical Device Companies

Infection Control Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Infection Control Market includes,

• 3M  Company

3M Company is an American multinational conglomerate which is operating in US healthcare, worker safety, industries, and consumer goods. The company produce 60,000 products which includes abrasives, adhesives, medical products, dental & orthodontic products, personal protective equipment, healthcare software & optical films. It offers single use & single-patient use products, science based solutions to protect patients and healthcare workers from cross contamination and medical equipment.

• Steris Corporation

Steris is the leading global provider of products & services which helps in supporting patient care with an emphasis on infection prevention. Steris is an Irish domiciled medical equipment company which is specialized in surgical products and sterilization for US healthcare system.

• BioInteractions Ltd.

BioInteractions Ltd., is a research & development company which is specialized in biomaterial technologies for worldwide medical device industry. BioInteractions develop innovative biocompatible solutions for medical devices used in medical procedures and treatment.

• Cantel Medical Corp.

Cantel is the global company which delivers innovative infection prevention products & services for care-givers, patients, and healthcare providers. They provides high quality infection prevention solutions and surpassed services.

• Getinge AB

Getinge AB is situated in Halmstad Municipality, Halland County, Sweden is medical technology company which is specialized in providing systems, equipment, intensive care units and operating rooms for healthcare and life science industries.

• Johnson & Johnson Services Inc.

Johnson & Johnson Services Inc., is the global leader in medical devices for treating orthopaedic trauma. The company has focused in specialty areas like infectious disease & vaccines, cardiovascular & metabolism, oncology, neuroscience, pulmonary hypertension & immunology.

• Danaher

Danaher is an innovative company in developing leading-edge diagnostic tools, protecting global food & water supplies, and advancing life-saving scientific research. The company offer products like, automate liquid handling solutions, instruments like centrifuge, cell counters, flow cytometry, air particle counters, etc.

• Ecolab

Ecolab, is the global leader in water, hygiene & infection prevention solutions & services which help in protecting planet, people and business health. Ecolab delivers data driven insights, science based solutions, and world class service to advance safety of food.

• Sterigenics International LLC.

Sterigenics is the global leader in comprehensive sterilization solutions which meets industrial sterilization needs in pharmaceutical, medical devices, commercial & food industries, etc.

• Belimed AG

Belimed is a leading supplier in medical and surgical instrument, disinfection, sterilization, cleaning products and services. The company is the global leader in infection control products for more than 40 years of experience. It provides best solutions for reprocessing medical equipment and other.

• Advanced Sterilization Products

Advanced Sterilization Products, is a leader in infection prevention, solutions & processes needed by practitioners, creating the products to protect patients during critical moments. They are also advancing infection prevention technologies.

Recent Development:

• In April 2022, BioInteractions Ltd., a UK biomaterial technology company has launched new medical device ‘TridAnt’ coating technology in prevention and protection of infection against wide range of pathogens. Newly launched ‘TridAnt’ helps in incorporating active & passive components for creating safe, effective, durable and non-leaching antimicrobial coating for implants and medical devices.

• BioInteractions Ltd. *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• 3M Company
• Steris Corporation
• Cantel Medical Corp.
• Getinge AB
• Johnson & Johnson Services Inc.
• Danaher
• Ecolab
• Sterigenics International LLC.
• Belimed AG
• Advanced Sterilization Products

“*” marked represents similar segmentation in other categories in the respective section.